Navigation Links
AmbiCom Forms Joint Alliance With E-Care Technology Corporation
Date:6/13/2011

MILPITAS, Calif., June 13, 2011 /PRNewswire/ -- AmbiCom Holdings, Inc. (OTCQB: ABHI), a leader in the development of wireless products for medical equipment suppliers, today announced that it has signed an agreement to form a joint alliance between its AmbiCom Technology, Inc. ("ATI") subsidiary and E-Care Technology Corporation, ("ECT") Taiwan. The agreement became effective May 1, 2011 and runs for a period of three years.

ECT is a leading manufacturer of infrared ear thermometers in Taiwan and also develops other medical devices such as intra-oral camera (dental camera). Under this joint alliance, ECT will develop, test and manufacture infrared ear thermometers and other medical devices as ATI private-labeled products under the brand name "E-Care USA, Inc." This agreement effectively gives AmbiCom new access to the $304 million market for wirelessly connected home health care devices.

"The joint alliance enables us to aggressively enter the home health care market with a differentiated, state-of-the-art suite of products utilizing our wireless technology platform," commented John Hwang, CEO and Chairman of AmbiCom. "As discussions with ECT progressed, it became clear that a joint alliance was more favorable to our shareholders than the previously contemplated merger, as this agreement provides AmbiCom with access to state-of-the-art medical devices and robust engineering to integrate our wireless communications components. Together, we expect to develop and introduce a superior product to US customers by the end of this year. This is another example of our solid relationships within the medical device industry, and we expect the joint alliance will allow both of our companies to leverage their core competencies cost effectively, in order to deliver this product and potential follow-on products in a timely manner."

About AmbiCom

AmbiCom is headquartered in Milpitas, California, and is a leading designer and developer of wireless products focusing on the wireless medical industry. The Company's wireless modules and devices are based on the Company's innovative application software for both Wi-Fi and Bluetooth technologies. AmbiCom is committed to wireless design and development of software and hardware, and to bringing new and innovative products to the wireless medical markets and other sectors. The Company plans to grow organically, and to augment that growth by selectively acquiring complementary products and technologies via acquisition opportunities deemed to be of strategic value.

Forward-Looking Statements

This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements including, but not limited to, our ability to maintain our website and associated computer systems, our ability generate sufficient market acceptance for our shipping products and services, our inability to generate sufficient operating cash flow, and general economic conditions. Readers are urged to carefully review and consider the various disclosures made by us in the our reports filed with the Securities and Exchange Commission, including those risks set forth in the Company's Current Report on Form 8-K filed on November 13, 2007, which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward- looking statements in order to reflect any event or circumstance that may arise after the date of this release.

Contact:
Dave Fore, Client Manager and Senior Research Analyst, Hayden IR: (206) 395-2711 or dave@haydenir.com


'/>"/>
SOURCE AmbiCom Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AmbiCom Retains Hayden IR to Develop Strategic Investor Relations Program
2. Major Medical Diagnostics Manufacturer Signs Agreement to Use AmbiCom Wireless Solution in Its Urinalysis Product Line
3. AmbiCom Renews and Expands Line of Credit With East West Bank
4. Allegheny General Hospital Performs First Liver Transplant
5. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
6. UBC Forms European Advisory Board to Enhance Data Quality of CNS Trials
7. Spirit II Results Support Strength of Boston Scientifics Two Drug-Eluting Stent Platforms
8. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
9. Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center
10. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
11. InNexus Lead Candidate DXL625 Outperforms Rituxan in Additional Animal Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... ... The American College of Medical Informatics (ACMI) will present the 2017 Morris F. ... AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is taking place ... the field of medical informatics, this prestigious award is presented to an individual whose ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in healthcare events ... Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the ... The annual award competition recognizes editorial and design excellence across a range of sectors. ...
(Date:10/12/2017)... ... , ... On Saturday, October 21, the Health & Wellness Center at Florida ... money for the American Heart Association Heart Walk. Teams of up to 10 people ... keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. on ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
Breaking Medicine News(10 mins):